Cue Advisory Services’s GSK GSK Stock Holding History

Cue Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12,104	Closed	-$630K	–	153
2015 Q2	$630K	Buy	12,104 +811	+7%	+$45.7K	0.59%	71
2015 Q1	$655K	Buy	11,293 +707	+7%	+$40.5K	0.66%	64
2014 Q4	$566K	Buy	+10,586	New	+$592K	0.59%	73

Other funds holding GSK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cue Advisory Services's GSK Position: Q3 2015 in Review

Cue Advisory Services sold out of GSK (GSK) in Q3 2015, closing a stake of 12,104 shares — an estimated $630K sold.

Cue Advisory Services first reported a position in GSK in Q4 2014 and held it in 3 quarters. The position peaked at $655K in Q1 2015. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

Cue Advisory Services reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
Cue Advisory Services sold 12,104 GSK shares in Q3 2015, an estimated $630K.
Cue Advisory Services first reported a position in GSK in Q4 2014 and held it in 3 quarters.
Cue Advisory Services's GSK position peaked at $655K in Q1 2015.
706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Cue Advisory Services's 13F filing for Q3 2015, filed 20 Oct 2015.